The mTOR pathway was considered to play a central role in cell growth and metabolism regulating in renal cell carcinomas oncogenesis and the activation of mTOR results in the downregulation of fumarase and fumarate accumulation in Tsc1-deficient animals and cells [24,30]. This evidence concerns the gene FH and renal cell carcinoma.